To estimate CD30 CAR-T cell proliferation upon tumor challenge, we then co-cultured anti-CD30 CAR-T and control T cells with irradiated HD-LM2 for 72 h at E:T ratio 1:1. Here, TNFRSF8 is linked to neoplasm.